Circular RNA dehydrodolichyl diphosphate synthase facilitated triple-negative breast cancer progression via

Suping Cui1,2, Yong Zhang1,2, Li Xing1,2

  • 1Department of Pathology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.

Abstract

Insights

Circular RNA dehydrodolichyl diphosphate synthase (circDHDDS) promotes triple-negative breast cancer (TNBC) by increasing DEAD box polypeptide 5 (DDX5) via sponging microRNA-362-3p. CircDHDDS deficiency inhibits TNBC cell proliferation, migration, invasion, and angiogenesis while promoting apoptosis.

Area of Science:

  • Molecular Oncology
  • Cancer Biology
  • Epigenetics

Background:

  • Triple-negative breast cancer (TNBC) is an aggressive subtype with limited therapeutic targets.
  • Circular RNAs (circRNAs) are emerging as critical regulators in cancer, but their roles in TNBC are not fully understood.
  • This study investigates the function and mechanism of circRNA dehydrodolichyl diphosphate synthase (circDHDDS) in TNBC pathogenesis.

Purpose of the Study:

  • To elucidate the role and molecular mechanism of circDHDDS in triple-negative breast cancer.
  • To determine the regulatory relationship between circDHDDS, microRNA-362-3p (miR-362-3p), and DEAD box polypeptide 5 (DDX5) in TNBC.

Main Methods:

  • Quantitative real-time PCR and western blot were used to measure expression levels of circDHDDS, DDX5, and miR-362-3p.
  • Cellular assays including colony formation, EdU, flow cytometry, transwell, and tube formation assays assessed proliferation, apoptosis, migration, invasion, and angiogenesis.
  • Dual-luciferase reporter assays and in vivo experiments validated the molecular interactions and functional effects of circDHDDS.

Main Results:

  • CircDHDDS and DDX5 expression were upregulated, while miR-362-3p was downregulated in TNBC tissues and cells.
  • CircDHDDS knockdown suppressed TNBC cell proliferation, migration, invasion, and angiogenesis, and induced apoptosis.
  • CircDHDDS acts as a molecular sponge for miR-362-3p, thereby increasing DDX5 expression, which promotes TNBC development.

Conclusions:

  • CircDHDDS significantly promotes TNBC progression by upregulating DDX5 expression through the sponging of miR-362-3p.
  • CircDHDDS represents a potential therapeutic target for triple-negative breast cancer.
  • The circDHDDS/miR-362-3p/DDX5 axis plays a crucial role in TNBC tumorigenesis.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K